Fieldpoint Private Securities’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CRM
Fieldpoint Private Securities's LMAT Position: Q2 2022 in Review
Fieldpoint Private Securities reduced its LeMaitre Vascular (LMAT) stake by 3.3% in Q2 2022, selling an estimated $1.88K and leaving 1,242 shares worth $57K. The position accounts for 0.02% of the portfolio, ranked #457.
Fieldpoint Private Securities first reported a position in LMAT in Q2 2019 and has held it in 10 quarters since. The position peaked at $63K in Q2 2021. 178 funds tracked by Wall St. Rank hold LMAT as of Q2 2022.
- Fieldpoint Private Securities held 1,242 shares of LeMaitre Vascular worth $57K as of Q2 2022.
- Fieldpoint Private Securities sold 42 LeMaitre Vascular shares in Q2 2022, an estimated $1.88K.
- LeMaitre Vascular made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #457 holding.
- Fieldpoint Private Securities first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 10 quarters since.
- Fieldpoint Private Securities's LeMaitre Vascular position peaked at $63K in Q2 2021.
- 178 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2022.
Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.